Skip to main content
Clinical Trials/CTRI/2021/07/034946
CTRI/2021/07/034946Not yet recruiting未知

Efficacy and safety of saroglitazar alone and in combination with vitamin E in case of non alcoholic steatohepatitis

Pt BD Sharma PGIMS Rohtak0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Patients 18-70 years of age of either gender
  • 2. Patients having alanine aminotransferase > 2 times of upper limit of normal (80-100 U/L) and ultrasound abdomen showing fatty liver
  • 3. Patients with non-significant history of alcohol ( <10 gram/day for females, <20 gram/day for males), negative viral markers.

Exclusion Criteria

  • 1. Patients with chronic liver disease other than non-alcoholic steatohepatitis
  • 2. Patients with chronic kidney diseases
  • 3. Patients with ischemic heart disease
  • 4. Patients with cerebrovascular disease
  • 5. Patients with chronic obstructive pulmonary disease
  • 6. Prior exposure to saroglitazar
  • 7. Patients with hepatocellular carcinoma
  • 8. Pregnant females
  • 9. Conjugated hyperbilirubinemia

Investigators

Sponsor
Pt BD Sharma PGIMS Rohtak

Similar Trials